AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Scope & Guideline

Innovating the Future of Neuropsychiatric Research

Introduction

Welcome to your portal for understanding AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1552-4841
PublisherWILEY
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1995 to 2024
AbbreviationAM J MED GENET B / Am. J. Med. Genet. B
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The American Journal of Medical Genetics Part B: Neuropsychiatric Genetics focuses on the genetic underpinnings of neuropsychiatric disorders. The journal aims to disseminate research findings that elucidate the complex relationship between genetics and mental health, employing various methodologies to advance understanding in this critical area.
  1. Genetic and Environmental Influences:
    Research emphasizing the interplay between genetic predispositions and environmental factors in the development of neuropsychiatric conditions, utilizing twin studies and family-based analyses.
  2. Polygenic Risk Scores and Their Applications:
    Investigation of polygenic risk scores to predict susceptibility to various psychiatric disorders, assessing their utility in clinical settings and for understanding population-level risks.
  3. Molecular Mechanisms of Psychiatric Disorders:
    Studies exploring the molecular pathways and genetic variants implicated in psychiatric disorders, including gene expression analysis and epigenetic modifications.
  4. Neurodevelopmental Genetics:
    Focus on genetic contributions to neurodevelopmental disorders, examining how genetic variants affect brain structure and function across the lifespan.
  5. Integration of Multi-Omics Data:
    Utilization of integrative approaches combining genomics, transcriptomics, and epigenomics to provide comprehensive insights into neuropsychiatric disorders.
The journal has seen a rise in interest in several emerging themes that highlight the evolving landscape of neuropsychiatric genetics. These trends indicate a growing complexity and integration of various scientific approaches to understanding mental health disorders.
  1. Artificial Intelligence in Psychiatry:
    The incorporation of network-based AI methodologies for personalized psychiatry signifies a trend toward leveraging computational techniques to enhance diagnostic and therapeutic strategies.
  2. Gut-Brain Axis Research:
    An increasing focus on the influence of gut microbiota on neuropsychiatric outcomes reflects a growing recognition of the gut-brain connection and its implications for mental health.
  3. Transdiagnostic Approaches:
    Research addressing genetic and phenotypic overlaps across multiple psychiatric disorders emphasizes a shift towards understanding shared mechanisms rather than isolated conditions.
  4. Impact of Polygenic Risk Scores on Clinical Outcomes:
    Emerging studies examining how polygenic risk scores influence treatment responses and clinical outcomes underscore the application of genetics in personalized medicine.
  5. Neuroimaging Genetics:
    The integration of neuroimaging data with genetic information to study brain structure and function in relation to psychiatric disorders is gaining prominence, providing deeper insights into the biological underpinnings of mental health.

Declining or Waning

While the journal has maintained a strong focus on various aspects of neuropsychiatric genetics, certain themes have shown a decline in prominence over recent years. These diminishing areas may reflect shifts in research priorities or evolving methodologies in the field.
  1. Historical Perspectives in Psychiatric Genetics:
    Fewer publications revisiting historical analyses or classic theories in psychiatric genetics suggest a move away from retrospective examinations toward more contemporary research frameworks.
  2. Single Gene Studies:
    A noticeable decline in studies focusing exclusively on single gene associations indicates a broader trend toward polygenic and multi-factorial approaches, reflecting the complexity of psychiatric disorders.
  3. Pharmacogenetics of Antipsychotic Medications:
    Research specifically targeting the pharmacogenetics of antipsychotics has diminished, possibly due to a shift in focus toward broader genetic and environmental interactions.

Similar Journals

MOLECULAR PSYCHIATRY

Unraveling the Complexities of the Mind at the Molecular Level
Publisher: SPRINGERNATUREISSN: 1359-4184Frequency: 12 issues/year

MOLECULAR PSYCHIATRY, published by SpringerNature, is a premier peer-reviewed journal that has established itself as a leading platform for the dissemination of cutting-edge research in the fields of neuroscience, molecular biology, and psychiatry. With an impressive impact factor and a reputation for excellence, the journal is ranked Q1 in key categories, signifying its high academic quality and relevance. The journal’s scope spans groundbreaking studies and innovative therapeutic approaches that intersect at the molecular and cellular levels, providing invaluable insights into the biological underpinnings of psychiatric disorders. Since its inception in 1996, MOLECULAR PSYCHIATRY has evolved to support both established and emerging researchers, fostering a collaborative environment that enhances the understanding of mental health. It is committed to improving access to scientific knowledge, although it currently does not offer open access options. With its headquarters in London, the journal continues to play a pivotal role in enhancing the global dialogue on psychiatric and neurological advancements, making it an essential resource for academics and professionals dedicated to advancing mental health sciences.

FOLIA BIOLOGICA

Exploring the Frontiers of Biochemistry and Beyond
Publisher: CHARLES UNIV PRAGUE, FIRST FACULTY MEDICINEISSN: 0015-5500Frequency: 6 issues/year

FOLIA BIOLOGICA, published by Charles University Prague, First Faculty of Medicine, is an esteemed academic journal that has been contributing to the fields of Biochemistry, Cell Biology, Developmental Biology, Genetics, Immunology, and Molecular Biology since its inception in 1961. With an ISSN of 0015-5500, this journal serves as a vital platform for researchers and professionals to disseminate their findings and advance knowledge within these disciplines. Despite its current Category Quartiles ranking in the lower tiers (Q3 and Q4), FOLIA BIOLOGICA continues to provide valued insights and foster scholarly dialogue, particularly in its paralleled fields. The journal is headquartered in Prague, Czech Republic, and operates without Open Access options, which emphasizes its focus on curated, peer-reviewed content essential for academicians and students. By bridging theoretical and practical knowledge, FOLIA BIOLOGICA remains committed to enriching the scientific community and serving as a cornerstone for future research innovations.

Translational Psychiatry

Bridging science and practice for a healthier mind.
Publisher: SPRINGERNATUREISSN: 2158-3188Frequency: 1 issue/year

Translational Psychiatry, an esteemed journal published by SpringerNature, is at the forefront of research in the fields of biological psychiatry, neuroscience, and mental health. With an impressive Q1 category ranking in Biological Psychiatry, Cellular and Molecular Neuroscience, and Psychiatry and Mental Health, the journal fosters high-quality scholarly work that informs clinical practices and guides future research directions. Since its inception in 2011, Translational Psychiatry has embraced the Open Access model, ensuring that groundbreaking findings are easily accessible to all, promoting collaboration and innovation within the global scientific community. With a solid ranking in Scopus—particularly at #33 out of 567 in Psychiatry and Mental Health and #6 out of 51 in Biological Psychiatry—this journal plays a critical role in advancing our understanding of mental health disorders, bridging the gap between bench science and clinical application. As it continues evolving through its converged years from 2011 to 2024, Translational Psychiatry remains an essential resource for researchers, healthcare professionals, and students dedicated to improving mental health outcomes.

GENETIC EPIDEMIOLOGY

Advancing the Science of Genetic Health
Publisher: WILEYISSN: 0741-0395Frequency: 8 issues/year

GENETIC EPIDEMIOLOGY is a pioneering journal published by Wiley that bridges the fields of genetics and epidemiology to advance our understanding of the genetic underpinnings of health and disease. Established in 1984 and converging into its 40th year of impactful research in 2024, this journal offers a key platform for the dissemination of innovative research findings, statistical methods, and applications in both clinical genetics and epidemiological practices. With a robust presence in Scopus, ranking in the second quartile (Q2) for both epidemiology and clinical genetics, it enjoys a significant reputation among its peers. The journal does not currently offer open access, but it is vital for researchers, professionals, and students committed to exploring the evolving landscape of genetic influences on population health. Its rich repository of studies not only enhances knowledge but also informs public health policies and clinical practices worldwide, making it an indispensable resource for those seeking to innovate and apply genetic research in the quest for better health outcomes.

ANIMAL GENETICS

Exploring the Genetic Blueprint of Animal Life
Publisher: WILEYISSN: 0268-9146Frequency: 6 issues/year

ANIMAL GENETICS, published by WILEY, is a leading journal in the fields of Animal Science and Zoology, with a commendable Q1 classification for 2023, reflecting its critical role in advancing research and knowledge in animal genetics. Established in 1986, this journal has become a cornerstone for professionals, researchers, and students alike, providing a platform for innovative research that explores the genetic underpinnings of animal biology. With an ISSN of 0268-9146 and an E-ISSN of 1365-2052, it boasts a significant impact in both agricultural and biological sciences, as indicated by its ranking of #74 out of 490 in its category on Scopus, positioning it in the 85th percentile for Animal Science and Zoology. Readers can access high-quality, peer-reviewed articles that not only illuminate current advancements but also foster future research directions. While currently not an open access journal, ANIMAL GENETICS remains vital for anyone engaged in the exploration of genetics and its applications in medicine and beyond, with a continual commitment to publishing findings that shape the future of animal breeding, conservation, and genetics research.

Noropsikiyatri Arsivi-Archives of Neuropsychiatry

Advancing the Frontiers of Neuropsychiatry
Publisher: TURKISH NEUROPSYCHIATRY ASSOC-TURK NOROPSIKIYATRI DERNEGIISSN: 1300-0667Frequency: 4 issues/year

Noropsikiyatri Arsivi-Archives of Neuropsychiatry is a prominent scholarly journal dedicated to advancing knowledge in the fields of neuropsychiatry and mental health. Published by the Turkish Neuropsychiatry Association, this journal aims to disseminate high-quality research that contributes to a deeper understanding of psychiatric disorders, innovative treatment modalities, and interdisciplinary approaches in neuroscience. Based in Turkey, the journal has been in circulation since its inception, with a rich history reflecting its commitment to addressing contemporary issues in mental health care. It is currently indexed under Scopus, with notable rankings in both Psychiatry and Mental Health (Rank #378/567, 33rd Percentile) and General Neuroscience (Rank #97/113, 14th Percentile), highlighting its increasing relevance and impact in the academia. Although it is not currently an open access journal, its contributions remain vital for researchers, professionals, and students who wish to stay abreast of the latest developments and research in neuropsychiatry.

Human Genomics

Elevating Genomic Research to New Heights
Publisher: BMCISSN: 1473-9542Frequency: 1 issue/year

Human Genomics, published by BMC, is a leading open-access journal dedicated to advancing the field of genomics and its applications in health and disease. Since its inception in 2003, the journal has provided a vital platform for researchers to disseminate groundbreaking findings related to genetic research, contributing significantly to areas such as Drug Discovery, Genetics, Molecular Biology, and Molecular Medicine, as reflected in its Q1 and Q2 quartile rankings throughout 2023. With an ISSN of 1473-9542 and an E-ISSN of 1479-7364, Human Genomics not only delivers high-quality, peer-reviewed research but also ensures accessibility to a broader audience, empowering professionals, students, and academics to stay at the forefront of genomic science. Through its rigorous editorial standards and impactful publications, the journal fosters a collaborative environment for innovative research across the globe from its base in the United Kingdom. By promoting open access since its launch, Human Genomics continues to enhance the visibility and impact of genetic studies, making it an essential resource for anyone involved in the rapidly evolving field of human genomics.

PSYCHIATRIC GENETICS

Connecting Genetics with Psychiatry: Pioneering New Frontiers
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0955-8829Frequency: 6 issues/year

PSYCHIATRIC GENETICS, published by LIPPINCOTT WILLIAMS & WILKINS, is a pivotal journal dedicated to the interdisciplinary study of genetic factors in psychiatric disorders, bridging the fields of genetics, psychiatry, and neuroscience. With a commitment to advancing research from its inception in 1990 and continuing through 2024, the journal provides a platform for innovative studies and findings that explore the genetic underpinnings of mental health. Although not currently an Open Access publication, it reaches a wide audience concerned with the complex interplay between genetics and psychiatric conditions, contributing to its Q3 and Q2 quartile rankings across multiple relevant categories in 2023. The importance of this journal cannot be understated; it serves as a crucial resource for researchers, clinicians, and students eager to uncover insights that could lead to more effective interventions and treatments in the realm of mental health.

EvoDevo

Innovating Research at the Intersection of Biology
Publisher: BMCISSN: Frequency: 1 issue/year

EvoDevo, published by BMC, is a premier open-access journal dedicated to the fields of Developmental Biology, Ecology, Evolution, Behavior and Systematics, and Genetics. With an impressive Q1 ranking in its category for 2023, EvoDevo stands out as a significant resource for researchers, professionals, and students seeking to explore the intricate relationships between evolutionary processes and developmental mechanisms. Since its inception in 2010, this UK-based journal has provided a platform for innovative research and insights, boasting rigorous peer-review standards that ensure high-quality publications. With the E-ISSN of 2041-9139 and a commitment to freely accessible research, EvoDevo is positioned at the forefront of scientific discourse, making vital contributions to our understanding of biological complexities. As the journal converges years from 2010 to 2024, it serves as a cornerstone for knowledge dissemination, inspiring future research trajectories in evolutionary developmental biology.

Journal of Genetics and Genomics

Exploring the Frontiers of Genetic Science
Publisher: SCIENCE PRESSISSN: 1673-8527Frequency: 12 issues/year

The Journal of Genetics and Genomics, published by SCIENCE PRESS in China, stands as a significant contributor to the fields of Genetics and Molecular Biology. With an ISSN of 1673-8527 and E-ISSN 1873-5533, this esteemed journal has achieved a remarkable reputation, holding a prestigious Q1 ranking in both Genetics and Molecular Biology as of 2023. This journal not only showcases pioneering research but also fosters vital discussions on contemporary challenges and innovations within genomic sciences. As part of its commitment to facilitating scientific advancement, the journal encompasses a range of research articles, reviews, and short communications, all aiming to illuminate the complexities of genetic structures and functions from 2007 to 2024. Researchers, professionals, and students alike are encouraged to engage with its content, which ranks favorably in Scopus—placing it within the top tier of its categories. Join the community of academic excellence and explore the latest findings that shape our understanding of genomics.